CD33+ Immature Myeloid Cells Critically Predict Recurrence in Advanced Gastric Cancer
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Journal of Surgical Research
- Vol. 245, 552-563
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (15K10148)
- Kanae Foundation for the Promotion of Medical Science
- Yasuda Memorial Foundation
This publication has 57 references indexed in Scilit:
- Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer, 2013
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and MetastasisCell, 2012
- MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapyInternational Immunopharmacology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Differential expression of constitutive and inducible proteasome subunits in human monocyte‐derived DC differentiated in the presence of IFN‐α or IL‐4European Journal of Immunology, 2009
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008
- Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancerJournal of Surgical Oncology, 2005
- Inflammation and cancerNature, 2002